
Microbiome Sequencing Services Market Report and Forecast 2025-2034
Description
The global microbiome sequencing services market size was valued at USD 2.17 Billion in 2024 , driven by the rising number of dental caries among all age groups across the globe. The market size is anticipated to grow at a CAGR of 20.60% during the forecast period of 2025-2034 to achieve a value of USD 14.12 Billion by 2034 .
Microbiome Sequencing Services: Introduction
Microbiome sequencing is a method of decoding the genetic material of all the microorganisms in a sample including bacteria, virus, fungi, and protists. There are two major methods that are used, one is whole genome shotgun sequencing (WGS), and the other one is amplicon sequencing. WGS is an unbiased method that detects all the genetic material in the sample. Amplicon sequencing targets a portion of the genetic material that is shared among the microorganisms but contains regions of variability that allow their identification. Identification of microorganisms in a sample by sequencing techniques and data analysis allows several advantages over traditional culturing approaches.
Global Microbiome Sequencing Services Market Analysis
The increasing demand for personalized supplements or treatments among the patients is directly influencing the market growth. The pharmaceutical companies are investing heavily in the development of more customer centric medications, such as personalized medications and supplements. For example, DSM Venturing has invested in a crop of startup Sun Genomics, which is taking advantage of the growing precision of microbiome research. The approach is expected to combine whole-genome sequencing with gut composition analysis to produce personalized supplements for each customer. The continuously ongoing explorations, heavy investments, developments of new innovative products are strongly anticipated to boost the global microbiome sequencing services market demand.
The increasing research and development activities to explore the potential of microbiome sequencing in body parts other than the gut has also been creating traction. There are several companies that have already begun to develop products targeting them. The increasing utilization of microbiome sequencing services towards skin is being used as basis for cosmetics.
Global Microbiome Sequencing Services Market Segmentations
Microbiome Sequencing Services Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Products and Services
The rising number of research and development activities and clinical trials due to the increasing awareness about the potential of microbiome associated with health and diseases is a major factor driving the market growth.
As result of various studies, microbiome has been proven to have the ability to be used in the production of personalized medicines, which works by targeting the issue. This ability of microbiome to be used to produce personalized medicine for better patient outcomes, there has been a surge in the demand for personalized medicine in the market. The increasing demand and awareness about personalized medicines is further propelling the global microbiome sequencing services market growth.
The rising prevalence of chronic diseases, such as obesity, diabetes, and inflammatory bowel disorders, is a major factor responsible for the increased since these medical conditions may require personalized medicines for the patients depending upon their genetic arrangements.
There has been an interest developing recently towards exploring the potential of microbiome sequencing services in learning more about the connections between the gut and the brain health which is further expected to aid the global microbiome sequencing services market share. The expansion of microbiome sequencing services fields other than pharmaceuticals such as cosmetics are also expected to support the market expansion.
Microbiome Sequencing Services Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Microbiome Sequencing Services: Introduction
Microbiome sequencing is a method of decoding the genetic material of all the microorganisms in a sample including bacteria, virus, fungi, and protists. There are two major methods that are used, one is whole genome shotgun sequencing (WGS), and the other one is amplicon sequencing. WGS is an unbiased method that detects all the genetic material in the sample. Amplicon sequencing targets a portion of the genetic material that is shared among the microorganisms but contains regions of variability that allow their identification. Identification of microorganisms in a sample by sequencing techniques and data analysis allows several advantages over traditional culturing approaches.
Global Microbiome Sequencing Services Market Analysis
The increasing demand for personalized supplements or treatments among the patients is directly influencing the market growth. The pharmaceutical companies are investing heavily in the development of more customer centric medications, such as personalized medications and supplements. For example, DSM Venturing has invested in a crop of startup Sun Genomics, which is taking advantage of the growing precision of microbiome research. The approach is expected to combine whole-genome sequencing with gut composition analysis to produce personalized supplements for each customer. The continuously ongoing explorations, heavy investments, developments of new innovative products are strongly anticipated to boost the global microbiome sequencing services market demand.
The increasing research and development activities to explore the potential of microbiome sequencing in body parts other than the gut has also been creating traction. There are several companies that have already begun to develop products targeting them. The increasing utilization of microbiome sequencing services towards skin is being used as basis for cosmetics.
Global Microbiome Sequencing Services Market Segmentations
Microbiome Sequencing Services Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Products and Services
- Reagents and Consumables
- Instruments
- Services
- Sequencing by Synthesis
- Sequencing by Ligation
- Shotgun Sequencing
- Sanger Sequencing
- Pyrosequencing
- Other Technologies
- Drug Development
- Agriculture and Food Industry
- Environmental Monitoring
- Others
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The rising number of research and development activities and clinical trials due to the increasing awareness about the potential of microbiome associated with health and diseases is a major factor driving the market growth.
As result of various studies, microbiome has been proven to have the ability to be used in the production of personalized medicines, which works by targeting the issue. This ability of microbiome to be used to produce personalized medicine for better patient outcomes, there has been a surge in the demand for personalized medicine in the market. The increasing demand and awareness about personalized medicines is further propelling the global microbiome sequencing services market growth.
The rising prevalence of chronic diseases, such as obesity, diabetes, and inflammatory bowel disorders, is a major factor responsible for the increased since these medical conditions may require personalized medicines for the patients depending upon their genetic arrangements.
There has been an interest developing recently towards exploring the potential of microbiome sequencing services in learning more about the connections between the gut and the brain health which is further expected to aid the global microbiome sequencing services market share. The expansion of microbiome sequencing services fields other than pharmaceuticals such as cosmetics are also expected to support the market expansion.
Microbiome Sequencing Services Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies Ltd.
- Qiagen N.V.
- BaseClear B.V.
- Zymo Research Corporation
- Second Genome
- Microbiome Insights Inc.
- CosmosID Inc.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Microbiome Sequencing Services Market Overview
- 3.1 Global Microbiome Sequencing Services Market Historical Value (2018-2024)
- 3.2 Global Microbiome Sequencing Services Market Forecast Value (2025-2034)
- 4 Global Microbiome Sequencing Services Market Landscape
- 4.1 Global Microbiome Sequencing Services Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Microbiome Sequencing Services Product Landscape
- 4.2.1 Analysis by Product and Services
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Microbiome Sequencing Services Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Microbiome Sequencing Services Market Segmentation
- 6.1 Global Microbiome Sequencing Services Market by Products and Services
- 6.1.1 Market Overview
- 6.1.2 Reagents and Consumables
- 6.1.3 Instruments
- 6.1.4 Services
- 6.2 Global Microbiome Sequencing Services Market by Technology
- 6.2.1 Market Overview
- 6.2.2 Sequencing by Synthesis
- 6.2.3 Sequencing by Ligation
- 6.2.4 Shotgun Sequencing
- 6.2.5 Sanger Sequencing
- 6.2.6 Pyrosequencing
- 6.2.7 Other Technologies
- 6.3 Global Microbiome Sequencing Services Market by Applications
- 6.3.1 Market Overview
- 6.3.2 Drug Development
- 6.3.3 Agriculture and Food Industry
- 6.3.4 Environmental Monitoring
- 6.3.5 Others
- 6.4 Global Microbiome Sequencing Services Market by End Use
- 6.4.1 Market Overview
- 6.4.2 Academic and Research Institutes
- 6.4.3 Pharmaceutical and Biotechnology Companies
- 6.4.4 Contract Research Organizations (CROs)
- 6.4.5 Others
- 6.5 Global Microbiome Sequencing Services Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Microbiome Sequencing Services Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Microbiome Sequencing Services Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Microbiome Sequencing Services Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Microbiome Sequencing Services Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Microbiome Sequencing Services Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Grants Analysis
- 12.1 Analysis by year
- 12.2 Analysis by Amount Awarded
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Grant Application
- 12.5 Analysis by Funding Institute
- 12.6 Analysis by NIH Departments
- 12.7 Analysis by Recipient Organization
- 13 Funding Analysis
- 13.1 Analysis by Funding Instances
- 13.2 Analysis by Type of Funding
- 13.3 Analysis by Funding Amount
- 13.4 Analysis by Leading Players
- 13.5 Analysis by Leading Investors
- 13.6 Analysis by Geography
- 14 Partnership and Collaborations Analysis
- 14.1 Analysis by Partnership Instances
- 14.2 Analysis by Type of Partnership
- 14.3 Analysis by Leading Players
- 14.4 Analysis by Geography
- 15 Regulatory Framework
- 15.1 Regulatory Overview
- 15.1.1 US FDA
- 15.1.2 EU EMA
- 15.1.3 INDIA CDSCO
- 15.1.4 JAPAN PMDA
- 15.1.5 Others
- 16 Supplier Landscape
- 16.1 Illumina, Inc.
- 16.1.1 Financial Analysis
- 16.1.2 Product Portfolio
- 16.1.3 Demographic Reach and Achievements
- 16.1.4 Mergers and Acquisition
- 16.1.5 Certifications
- 16.2 Thermo Fisher Scientific, Inc.
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisition
- 16.2.5 Certifications
- 16.3 Pacific Biosciences of California, Inc.
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisition
- 16.3.5 Certifications
- 16.4 Oxford Nanopore Technologies Ltd.
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisition
- 16.4.5 Certifications
- 16.5 Qiagen N.V.
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisition
- 16.5.5 Certifications
- 16.6 BaseClear B.V.
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisition
- 16.6.5 Certifications
- 16.7 Zymo Research Corporation
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisition
- 16.7.5 Certifications
- 16.8 Second Genome
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisition
- 16.8.5 Certifications
- 16.9 Microbiome Insights Inc.
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisition
- 16.9.5 Certifications
- 16.10 CosmosID Inc.
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisition
- 16.10.5 Certifications
- 17 Global Microbiome Sequencing Services Market - Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.